These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28105110)

  • 21. Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model.
    Pattni BS; Nagelli SG; Aryasomayajula B; Deshpande PP; Kulkarni A; Hartner WC; Thakur G; Degterev A; Torchilin VP
    Pharm Res; 2016 Oct; 33(10):2540-51. PubMed ID: 27351426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin.
    Hong M; Zhu S; Jiang Y; Tang G; Pei Y
    J Control Release; 2009 Jan; 133(2):96-102. PubMed ID: 18840485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting of post-ischemic cerebral endothelium in rat by liposomes bearing polyethylene glycol-coupled transferrin.
    Omori N; Maruyama K; Jin G; Li F; Wang SJ; Hamakawa Y; Sato K; Nagano I; Shoji M; Abe K
    Neurol Res; 2003 Apr; 25(3):275-9. PubMed ID: 12739237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WT1 gene silencing by aerosol delivery of PEI-RNAi complexes inhibits B16-F10 lung metastases growth.
    Zamora-Avila DE; Zapata-Benavides P; Franco-Molina MA; Saavedra-Alonso S; Trejo-Avila LM; Reséndez-Pérez D; Méndez-Vázquez JL; Isaias-Badillo J; Rodríguez-Padilla C
    Cancer Gene Ther; 2009 Dec; 16(12):892-9. PubMed ID: 19461674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of 9-nitrocamptothecin-in-cyclodextrin-in-liposomes modified with transferrin for the treating of tumor.
    Chen J; Lu S; Gu W; Peng P; Dong J; Xu F; Yang X; Xiong Z; Yang X
    Int J Pharm; 2015 Jul; 490(1-2):219-28. PubMed ID: 26004006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
    Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
    J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasmid pORF-hTRAIL targeting to glioma using transferrin-modified polyamidoamine dendrimer.
    Gao S; Li J; Jiang C; Hong B; Hao B
    Drug Des Devel Ther; 2016; 10():1-11. PubMed ID: 26719669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
    Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
    Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Silencing effect of cell-specific RNA interference plasmid pPSMAe/p-shNS-ploy(A) loaded by transgenic vector Tf-PEG-PEI targeting nucleostemin on prostate cancer cells in vitro].
    Liu RL; Wang WY; Zhang ZH; Xu Y
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):725-9. PubMed ID: 23291063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure.
    Mo L; Song JG; Lee H; Zhao M; Kim HY; Lee YJ; Ko HW; Han HK
    Nanomedicine; 2018 Feb; 14(2):557-567. PubMed ID: 29248675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transferrin-Conjugated Erianin-Loaded Liposomes Suppress the Growth of Liver Cancer by Modulating Oxidative Stress.
    Yang A; Sun Z; Liu R; Liu X; Zhang Y; Zhou Y; Qiu Y; Zhang X
    Front Oncol; 2021; 11():727605. PubMed ID: 34513705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-(10)B (GB-10) as (10)B-carriers for boron neutron capture therapy.
    Masunaga S; Kasaoka S; Maruyama K; Nigg D; Sakurai Y; Nagata K; Suzuki M; Kinashi Y; Maruhashi A; Ono K
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1515-22. PubMed ID: 17126210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes.
    Chiu SJ; Liu S; Perrotti D; Marcucci G; Lee RJ
    J Control Release; 2006 May; 112(2):199-207. PubMed ID: 16564596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using adenovirus armed short hairpin RNA targeting transforming growth factor β1 inhibits melanoma growth and metastasis in an ex vivo animal model.
    Tai KF; Wang CH
    Ann Plast Surg; 2013 Dec; 71 Suppl 1():S75-81. PubMed ID: 24284745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transferrin conjugation does not increase the efficiency of liposomal Foscan during in vitro photodynamic therapy of oesophageal cancer.
    Paszko E; Vaz GM; Ehrhardt C; Senge MO
    Eur J Pharm Sci; 2013 Jan; 48(1-2):202-10. PubMed ID: 23159666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transferrin and cell-penetrating peptide dual-functioned liposome for targeted drug delivery to glioma.
    Zheng C; Ma C; Bai E; Yang K; Xu R
    Int J Clin Exp Med; 2015; 8(2):1658-68. PubMed ID: 25932094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transferrin-conjugated liposomes loaded with carnosic acid inhibit liver cancer growth by inducing mitochondria-mediated apoptosis.
    Liu X; Dong S; Dong M; Li Y; Sun Z; Zhang X; Wang Y; Teng L; Wang D
    Int J Pharm; 2021 Sep; 607():121034. PubMed ID: 34425193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic delivery of Eg5 shRNA-expressing plasmids using PEGylated DC-Chol/DOPE cationic liposome: Long-term silencing and anticancer effects in vivo.
    Seraj S; Lee J; Ahn HJ
    Biochem Pharmacol; 2019 Aug; 166():192-202. PubMed ID: 31129050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transferrin-modified liposomes triggered with ultrasound to treat HeLa cells.
    AlSawaftah NM; Awad NS; Paul V; Kawak PS; Al-Sayah MH; Husseini GA
    Sci Rep; 2021 Jun; 11(1):11589. PubMed ID: 34078930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.